Understanding cell migration through microscale in vitro models
Understanding cell migration through microscale in vitro models
批准号:
8840701
负责人:
David J Beebe
金额:
$1.09万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2015-06-30
关键词:
ActinsAdaptor Signaling ProteinAddressAdhesionsAlzheimer&aposs DiseaseApoptosisAreaArthritisAsthmaBacterial InfectionsBiological AssayBloodCardiovascular DiseasesCellsChemicalsChemotaxisChronicCollaborationsComplexDefectDevelopmentDevicesDiseaseDisease modelEngineeringEnvironmentFingersFutureG-Protein-Coupled ReceptorsGoalsGrantHomologous GeneImmune System DiseasesImmune responseImmune systemIn VitroInborn Genetic DiseasesInflammationInflammatoryInflammatory Bowel DiseasesIntegrinsLifeMaintenanceMalignant NeoplasmsMediatingMethodsMicrofluidic MicrochipsMicrofluidicsMigration AssayMolecularMutationNeutropeniaNeutrophil InfiltrationParacrine CommunicationPathogenesisPathway interactionsPatientsPharmacologic SubstancePhysiciansPhysiologicalProcessResearchResearch PersonnelRoleSamplingSignal PathwaySignal TransductionStimulusSyndromeSystemTestingTimeTissuesValidationVenipuncturesWound Healingbasecell motilityhigh throughput screeninghuman EMS1 proteinhuman diseaseimprovedin vitro Modelin vivoinjuredinsightmethod developmentmigrationneutrophilnew therapeutic targetnovelnovel therapeutic interventiontherapeutic targettooltumor progressionwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cell migration is a complicated multistep process that is central to the pathogenesis of diverse disease processes. Although neutrophils are an essential part of the innate immune response, their inappropriate recruitment is central to chronic inflammatory disorders including asthma, arthritis and inflammatory bowel disease; and also contributes to the pathogenesis of other diseases such as cardiovascular disease, tumor progression and Alzheimer's disease. Chemotaxis, the movement of cells within a chemical gradient, is the fundamental process underlying neutrophil recruitment. Despite its importance, current tools limit progress towards understanding the molecular mechanisms that regulate cell migration. In particular, current methods are largely limited to 2D environments, require relatively large blood draws and use stimuli of questionable physiological relevance. Our goal is to use and further develop microscale methods and microscale in vitro models that overcome these challenges, enhancing our ability to identify signaling pathways that regulate cell polarization and directed motility in the context of disorders involving the innate immune system - specifically the role of Hax1 signaling in neutrophil chemotaxis in the context of severe congential neutropenia (SCN). Currently, chemotaxis studies are very time and labor intensive limiting the number of experimental conditions that can be explored. Our approach fundamentally changes the way a researcher can approach chemotaxis studies. Many more experimental conditions can be examined with the same time/effort. A key strength of this application lies in the use of novel (but simple) microfluidic devices that generate defined and stable chemical gradients that do not require laminar flow for gradient formation or maintenance and can be adapted to high throughput screening. In Aim 1, we will develop improved 3D assays that provide a more physiologically relevant context for cell migration and develop methods that allow the use of small volume finger stick samples. In Aim 2, we will develop microfluidic-based wound assays to analyze neutrophil recruitment through cell sourced gradients to determine factors that regulate cell polarization and directed cell migration in multicelluar environments In Aim 3, we propose to study how Hax1/HS1/G113 signaling modulates neutrophil motility and recruitment in more complex 3D and cell sourced gradients to mimic in vivo conditions. Using these systems, we will dissect how Hax1 regulates gradient sensing and directed cell migration with Hax1-deficient neutrophil-like PLB987 cells. Future applications will include analysis of neutrophil motility from patients presenting with neutropenia using 2D and 3D/cell sourced microfluidic systems to understand disease pathogenesis and identify novel therapeutic targets.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Gradient generation platforms: new directions for an established microfluidic technology.
梯度生成平台:已建立微流体技术的新方向。
DOI:
10.1039/c4lc00448e
发表时间:
2014-09-07
期刊:
Lab on a chip
影响因子:
6.1
作者:
[Berthier E, Beebe DJ]
通讯作者:
Beebe DJ
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
-
批准号:10733303
-
项目类别:
-
资助金额:$76.91万
-
财政年份:2023
-
负责人:David J Beebe
-
依托单位:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10333399
-
项目类别:
-
资助金额:$76.42万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10552700
-
项目类别:
-
资助金额:$77.08万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
-
批准号:10209529
-
项目类别:
-
资助金额:$72.84万
-
财政年份:2021
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:9916997
-
项目类别:
-
资助金额:$61.09万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10331769
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10686449
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10263962
-
项目类别:
-
资助金额:$85.43万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10094211
-
项目类别:
-
资助金额:$63.43万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10380807
-
项目类别:
-
资助金额:$36.04万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10132990
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
-
批准号:10552039
-
项目类别:
-
资助金额:$62.16万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10707411
-
项目类别:
-
资助金额:$77.75万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
-
批准号:10038030
-
项目类别:
-
资助金额:$77.54万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
-
批准号:10599320
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2020
-
负责人:David J Beebe
-
依托单位:
Microscale models of inflammation and its resolution
-
批准号:10372948
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2018
-
负责人:David J Beebe
-
依托单位:
Microscale models of inflammation and its resolution
-
批准号:9904469
-
项目类别:
-
资助金额:$75.23万
-
财政年份:2018
-
负责人:David J Beebe
-
依托单位:
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
-
批准号:10495294
-
项目类别:
-
资助金额:$37.09万
-
财政年份:2016
-
负责人:David J Beebe
-
依托单位:
Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
-
批准号:10673977
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2016
-
负责人:David J Beebe
-
依托单位:
An automated high-throughput tissue model for screening metastatic effectors
-
批准号:8817450
-
项目类别:
-
资助金额:$61.05万
-
财政年份:2015
-
负责人:David J Beebe
-
依托单位: